Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer

Concurrent chemoradiotherapy is the established treatment for locally advanced nasopharyngeal carcinoma (NPC). However, there is no evidence supporting routine adjuvant chemotherapy. We aimed to demonstrate the effect of adjuvant chemotherapy on survival and distant metastasis in high-risk N3 NPC pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Mu-Hung, Wu, Shang-Yin, Lu, Hsi-Huei, Yu, Tsung, Tsai, Sen-Tien, Wu, Yuan-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352661/
https://www.ncbi.nlm.nih.gov/pubmed/35927415
http://dx.doi.org/10.1038/s41598-022-16422-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352661/
https://www.ncbi.nlm.nih.gov/pubmed/35927415
http://dx.doi.org/10.1038/s41598-022-16422-w

Ejemplares similares